Among the LGBTQ+ population, why is HIV virologic suppression lower in the transgender and gender-diverse (trans) populations? Why are trans women 66 times more likely to be diagnosed with HIV than other individuals? What role does stigma play in delayed ART initiation? What do clinicians need to know about integrating trauma-informed care and education into their practices?
These are some of the questions advanced practice nurse Dallas Ducar, CEO of Transhealth, discusses in this issue of eHIV Review.
Chief Executive Officer, Transhealth
Faculty, Columbia University, Northeastern University, Universityof Virginia, the MGH Institute for Health Professions
(she/he/hers)
Assistant Professor of Medicine and Pharmacology and Molecular Sciences
Division of Infectious Diseases
Division of Clinical Pharmacology
Johns Hopkins School of Medicine
Baltimore, Maryland
(she/her/hers)
Assistant Professor
HIV, ID, and Global Medicine
Zuckerberg San Francisco General Hospital
San Francisco, California
(he/him/his)
Nurse Educator
Boston Medical Center
Boston, MA
(he/him/his)
1.0 hour Physicians
1.0 contact hour Nurses
Launch date: January 10, 2023
Expiration date: January 9, 2025